Source link : https://newshealth.biz/health-news/new-guidance-on-resmetirom-and-semaglutide-for-mash/

(MedPage Today) — At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on using resmetirom (Rezdiffra) and semaglutide (Ozempic, Wegovy) for metabolic dysfunction-associated steatohepatitis… Source link : https://www.medpagetoday.com/meetingcoverage/aasldvideopearls/118532 Author : Publish date : 2025-11-14 18:51:00 Copyright for syndicated content belongs to the linked Source.

The post New Guidance on Resmetirom and Semaglutide for MASH first appeared on News Health.

—-

Author : News Health

Publish date : 2025-11-14 18:51:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678